Moberg Pharma's Interim Report for July 2019 - March 2020 to be Published on May 12 - Invitation to Teleconference

STOCKHOLM, May 5, 2020 /PRNewswire/ -- On May 12^th, 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will present its Interim report for July 2019 - March 2020. Investors, analysts and journalists are hereby invited to participate in a teleconference at 3:00 pm (CET) on the same date.

The teleconference will be hosted by Moberg Pharmas's CEO Anna Ljung and VP Finance Mark Beveridge. The presentation will be held in English.

Date:  May 12^th, 2020
Time:  3:00 pm (CET)

To participate in the conference, please dial in on any number below before the start of the call:

SE:   +46 8 505 583 69
US:   +1 833 249 84 04

The quarterly report and other information material will be made public on:
http://www.mobergpharma.com/investors/calendarpresentations

For additional information, please contact:
Anna Ljung, CEO, Phone: + 46 70 766 60 30, e-post: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance, Phone: + 46 76 805 82 88, e-post: mark.beveridge@mobergpharma.se

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/moberg-pharma/r/moberg-pharma-s-interim-report-for-july-2019---march-2020-to-be-published-on-may-12---invitation-to-,c3103748

The following files are available for download:

View original content:http://www.prnewswire.com/news-releases/moberg-pharmas-interim-report-for-july-2019---march-2020-to-be-published-on-may-12---invitation-to-teleconference-301052617.html

SOURCE Moberg Pharma